Primary record
2,4,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
- 库存
- 8,408 克
- 纯度
- 98.2 %
- CAS
- 56281-36-8
化合物标识与属性
- CAS
- 56281-36-8
- PubChem CID
- 6314185
- SMILES
- CCNC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
- Canonical SMILES
- CCNC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C
名称与同义词
- Motretinide
- Tasmaderm
- Motretinida
- Motretinidum
- Motretinid
- Tmmp-era
- Tmmp ethyl ester
- molrelinid
- tasmadem
- Tasmaderm (TN)
- Motretinide [USAN:INN]
- Motretinidum [INN-Latin]
- Motretinida [INN-Spanish]
- Ro 11-1430
- 56281-36-8
- MOTRETINIDE [MI]
- RefChem:819546
- CCRIS 5815
- MOTRETINIDE [INN]
- (R)-2-benzylsuccinicacid
- Motretinide (USAN/INN)
- MOTRETINIDE [USAN]
- AC1O3R7Z
- SCHEMBL3546
- MOTRETINIDE [MART.]
- MOTRETINIDE [WHO-DD]
- Ro-11-1430
- UNII-W786807KL1
- NSC-351523
- DTXSID30878633
- EINECS 260-094-6
- CHEMBL519260
- orb1701907
- SCHEMBL29387245
- W786807KL1
- C23H31NO2
- BRN 2169960
- D10AD05
- DTXCID50910009
- CHEBI:135490
- IYIYMCASGKQOCZ-DJRRULDNSA-N
- Trimethylmethoxyphenyl-N-ethyl retinamide
- ZINC3812940
- C23-H31-N-O2
- NSC351523
- AKOS015964309
- CID6314185
- DB13368
- NSC 351523
- 54757-59-4
- (2E,4E,6E,8E)-N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide
- AC-18534
- J14.532G
- LS-96916
- HY-122299
- CS-0083489
- NS00056081
- J3.020.232E
- D05082
- 42138-EP2311808A1
- 42138-EP2311829A1
- Q904009
- 2,4,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
- all-trans-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide
- (all-E)-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide
- 2,4,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-
- 2,4,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
- n-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide
- trans-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide
- 2,4,6,8-Nonatetraenamide, 3,7-dimethyl-N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-, (all-E)-
- 2,4,6,8-Nonatetraenamide,9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl
- N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraeneamide
- N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide
- (2E,4E,6E,8E)-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dim ethyl-2,4,6,8-nonatetraenamide
- (2E,4E,6E,8E)-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide
- (2E,4E,6E,8E)-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetrenamide
- (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraen-1-oic acid ethyl amide
- 2,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all E)-
- 2,6,8-Nonatetraenamide, N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
- 260-094-6